Parkinson’s disease – TechConnect Briefs

Timed release of cerebrolysin using titanate nanospheres induces neuroprotection in Parkinson’s Disease

Sharma A., Sharma H.S., Muresanu D.F., Lafuente J.V., Ozkizilcik A., Tian Z.R., Patnaik R., Mössler H., Sharma A., Sharma H.S., Uppsala University, SE

Military personnel during combat operations are highly susceptible to traumatic brain and spinal cord injury. There are reasons to believe that a focal injury to the central nervous system (CNS) causes multiple biochemical and pathological [...]

Cerium Oxide Nanoparticles Protect Against MPTP-Induced Dopaminergic Neurodegeneration in a Mouse Model for Parkinson’s Disease

Dillon C.D., Billings M., Hockey K.S., DeLaGarza L., Rzigalinski B.A., Virginia College of Osteopathic Medicine, US

In this abstract, we demonstrate that cerium oxide nanoparticles protect against neurodegeneration in a mouse model of Parkinson’s Disease.

A Non-Oxidative Sensor Based on a Self-Doped Polyaniline/Carbon Nanotube Composite for Highly Sensitive and Selective Detection of the Neurotransmitter Dopamine

Ali S.R., Ma Y., Parajuli R.R., Balogan Y., Lai W.Y-C., He H., Rutgers University, US

The ability to measure the concentration of dopamine sensitively and selectively could potentially be used for molecular diagnosis of Parkinson’s disease. The ability to monitor its concentration in-vivo also benefits in design therapies and evaluating [...]